Defunct Company
Total Trials
14
As Lead Sponsor
As Collaborator
0
Total Enrollment
168,047
NCT03015454
An Algorithm Driven Sepsis Prediction Biomarker
Phase: N/A
Role: Lead Sponsor
Start: Dec 31, 2016
Completion: Not specified
NCT03960203
Effect of a Sepsis Prediction Algorithm on Clinical Outcomes
Start: Jan 31, 2017
Completion: Jun 30, 2018
NCT03235193
Predictive algoRithm for EValuation and Intervention in SEpsis
Start: Jul 1, 2017
Completion: Aug 30, 2017
NCT03212534
Inpatient Mortality Prediction Algorithm Clinical Trial (IMPACT)
Start: Jul 31, 2017
Completion: Oct 31, 2017
NCT03882476
RCT of Sepsis Machine Learning Algorithm
Phase: Phase 2
Start: Jan 1, 2020
Completion: Feb 28, 2021
NCT04423991
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning
Start: Mar 10, 2020
Completion: Jun 4, 2020
NCT04390516
Respiratory Decompensation and Model for the Triage of COVID-19 Patients
Start: Mar 24, 2020
Completion: May 30, 2020
NCT04358510
COVID-19 Mortality Prediction Model
Start: Apr 1, 2020
Completion: Apr 17, 2020
NCT04358536
Classification of COVID-19 Infection in Posteroanterior Chest X-rays
NCT04200950
Trial for the Early Identification of Acute Kidney Injury
Start: Jul 31, 2020
Completion: Jun 30, 2021
NCT03644940
Subpopulation-Specific Sepsis Identification Using Machine Learning
Start: Dec 31, 2020
Completion: Jul 31, 2021
NCT04005001
Machine Learning Sepsis Alert Notification Using Clinical Data
Start: Sep 25, 2021
Completion: Aug 31, 2022
NCT03752489
Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment
Start: Apr 1, 2022
Completion: Mar 31, 2024
NCT03734484
Gram Type Infection-Specific Sepsis Identification Using Machine Learning
Start: May 1, 2022
Completion: Mar 1, 2023